TriSalus Life Sciences and MD Anderson Cancer Center announce research collaboration to evaluate treatment of solid tumors

TriSalus Life Sciences and MD Anderson Cancer Center announce research collaboration to evaluate treatment of solid tumors

DENVER -- The University of Texas MD Anderson Cancer Center and Denver-based TriSalus Life Sciences announced a strategic research collaboration to evaluate the treatment of tumors of the... Read More

Thursday April 15, 2021 0 comments Tags: Denver, TriSalus Life Sciences, MD Anderson Cancer Center, Steven Katz

TriSalus Life Sciences appoints Steven Katz as chief medical officer

TriSalus Life Sciences appoints Steven Katz as chief medical officer

DENVER -- TriSalus Life Sciences announced the appointment of Steven Katz , M.D., as its chief medical officer. Katz will oversee the company’s clinical development strategy as it seeks to... Read More

Monday October 5, 2020 0 comments Tags: Denver, TriSalus Life Sciences, Steven Katz, Mary Szela

TriSalus Life Sciences lays out therapeutic strategy upon acquisition of first therapeutic candidate

TriSalus Life Sciences lays out therapeutic strategy upon acquisition of first therapeutic candidate

DENVER and CHICAGO -- TriSalus Life Sciences (TriSalus), an emerging immune-oncology company committed to transforming outcomes for patients with solid tumors, announced its therapeutic clinical... Read More

Monday September 28, 2020 0 comments Tags: Westminster, TriSalus Life Sciences, SD-101, Mats Wahlstrom, Mary Szela, Steven Katz